Winston-Salem, NC (PRWEB) August 13, 2014
PMG Research, Inc. announced today its designation as a Quintiles Prime Site. PMG Research provides clinical research services to large physician practices and integrated health systems, with access to 1.7 million patient lives. PMG Research is comprised of 10 hub site locations and spans 53 physician practices. PMG Research and Quintiles have been working together for 20 years to deliver clinical research solutions to the pharmaceutical industry.
The mission of PMG Research is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to its clinical trial partners and stakeholders. PMG Research, celebrating its 35th anniversary this year, has conducted over 7,100 trials for hundreds of pharmaceutical sponsors and CROs and has extensive experience conducting all phases of clinical research across a comprehensive list of conditions.
“We are incredibly proud to have been selected as a Quintiles Prime Site,” explains Jennifer Byrne, CEO of PMG Research. “Our broad therapeutic capabilities, strong regulatory track record, deeply engaged physician investigators, and continuously growing access to patients makes PMG Research a great fit for the Prime Site program. We look forward to taking what is already a highly collaborative relationship to the next level, building a transformational partnership that allows us to better achieve our mission: bringing clinical research to as many lives as possible.”
“The healthcare landscape is changing, and advances in science, analytics and therapeutic knowledge offer the promise of better treatments. The realization of this promise will only be possible by working differently, and our Prime Site program is an example of this,” explains Lindy Jones, Head of Integrated Patient & Site Strategies, Quintiles. "We are proud to be working with the team at PMG Research wit
Copyright©2014 Vocus, Inc.
All rights reserved